Alphagraph | Aurobindo Pharma Ltd (NSE: AUROPHARMA): Q4FY23 Results Out; Total Income rises 13% YoY.

Aurobindo Pharma is a leading pharmaceutical company primarily involved in the manufacturing and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services. The company specializes in the production of APIs, which are the key components of pharmaceutical formulations. Aurobindo Pharma also focuses on the development, manufacturing, and distribution of generic pharmaceuticals, providing cost-effective alternatives to branded medications. With its broad range of offerings, the company serves the healthcare industry by providing essential medicines and contributing to the accessibility and affordability of healthcare worldwide. Aurobindo Pharma’s commitment to quality and innovation has established its reputation as a trusted player in the pharmaceutical industry.